Year None202320222021202020182017201620152014 Mar 10, 2023 Kiromic BioPharma Announces Reverse Stock Split Feb 28, 2023 Kiromic BioPharma Reports Favorable Deltacel™ Preclinical Pharmacology Results Feb 23, 2023 Two Leading Independent Proxy Advisory Firms Recommend Kiromic BioPharma Stockholders Vote “FOR” All Proxy Proposals Feb 16, 2023 Kiromic BioPharma CEO Issues Letter to Stockholders
Feb 23, 2023 Two Leading Independent Proxy Advisory Firms Recommend Kiromic BioPharma Stockholders Vote “FOR” All Proxy Proposals
